← All candidates
Twelve insider buys in the last year — $3.61M in all.
27 filings on record.
TLSIWTriSalus Life Sciences, Inc.
NasdaqGM
$0.8900
+0.00% · Sep 15
Twelve insider buys in the last year — $3.61M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 12 buys● 1 sell◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Float
49.3M
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Stansky Michael P
Bought $1.02M on May 15 — 410,000 sh @ $2.50, held direct, 33% of their stake.
No completed positions to measure
Director
Wahlstrom Mats
Bought $151.8K on May 15 — 60,000 sh @ $2.53, held direct, 41% of their stake.
No completed positions to measure
CEO and President
Szela Mary T
Bought $125.0K on Feb 23 — 30,487 sh @ $4.10, held direct, 3.9% of their stake.
No completed positions to measure
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
17 more transactions on Pro →Context
Coverage
TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...GuruFocus.com · 05-13TriSalus Life Sciences Q1 Earnings Call HighlightsMarketBeat · 05-13TriSalus Life Sciences, Inc. Q1 2026 Earnings Call SummaryMoby · 05-13TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue EstimatesZacks · 05-12
The file stays open
27 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice